Biomere
Biomere is a global preclinical CRO specializing in efficacy, PK/PD, and ADME studies in rodent and large animal models, including primates. Acquired by JOINN Laboratories in 2019, it extends its capabilities worldwide, offering non-GLP and GLP studies with a focus on scientific expertise, dedicated project resourcing, and expedited study start times.
Industries
Nr. of Employees
medium (51-250)
Biomere
Worcester, Massachusetts, United States, North America
Services
End‑to‑end design and execution of in vivo efficacy and pharmacology studies across rodent and large animal models, including ophthalmology and oncology indications.
Comprehensive GLP and non‑GLP toxicology programs including DART, genetic toxicology, carcinogenicity and juvenile animal studies to support regulatory submissions.
Method development and GLP validation for PK/PD and biomarker assays, plus clinical and preclinical bioanalysis support.
Full‑service colony management including breeding to specification, genotyping, SNP panels, housing options, and study‑ready cohort delivery.
High‑parameter immune profiling, cell phenotyping, receptor occupancy analysis and functional assays for preclinical samples.
Cell line development, culture media formulation, scaleable fermentation (laboratory to industrial scale), analytical development and batch release testing for biologics.
End‑to‑end design and execution of in vivo efficacy and pharmacology studies across rodent and large animal models, including ophthalmology and oncology indications.
Comprehensive GLP and non‑GLP toxicology programs including DART, genetic toxicology, carcinogenicity and juvenile animal studies to support regulatory submissions.
Method development and GLP validation for PK/PD and biomarker assays, plus clinical and preclinical bioanalysis support.
Full‑service colony management including breeding to specification, genotyping, SNP panels, housing options, and study‑ready cohort delivery.
High‑parameter immune profiling, cell phenotyping, receptor occupancy analysis and functional assays for preclinical samples.
Cell line development, culture media formulation, scaleable fermentation (laboratory to industrial scale), analytical development and batch release testing for biologics.
Expertise Areas
- Preclinical study design and execution
- Pharmacokinetics, pharmacodynamics and DMPK
- GLP toxicology and IND‑enabling studies
- Animal model development and colony management
Key Technologies
- Flow cytometry and cell sorting
- Multiplex immunoassays (electrochemiluminescence and proximity formats)
- In vivo bioluminescence and optical imaging
- Quantitative PCR and SNP genotyping